SPIN1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.32319996573693E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.1476000411933E-09 |
Normal-vs-Stage2 |
9.007600E-04 |
Normal-vs-Stage3 |
1.22270000013636E-07 |
Normal-vs-Stage4 |
2.18329999999156E-05 |
Stage1-vs-Stage2 |
7.546600E-01 |
Stage1-vs-Stage3 |
4.246800E-01 |
Stage1-vs-Stage4 |
6.477400E-01 |
Stage2-vs-Stage3 |
3.036200E-01 |
Stage2-vs-Stage4 |
4.611400E-01 |
Stage3-vs-Stage4 |
9.498600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.11109995940495E-09 |
Normal-vs-AfricanAmerican |
3.61729999953653E-07 |
Normal-vs-Asian |
4.6732999999799E-06 |
Caucasian-vs-AfricanAmerican |
9.174600E-01 |
Caucasian-vs-Asian |
2.421000E-01 |
AfricanAmerican-vs-Asian |
1.983950E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.15599996242111E-09 |
Normal-vs-Female |
3.51980000000696E-05 |
Male-vs-Female |
3.629600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
6.77009999949796E-07 |
Normal-vs-Extreme_Weight |
2.63430000035925E-08 |
Normal-vs-Obese |
2.07839999999404E-05 |
Normal-vs-Extreme_Obese |
7.94760000000228E-05 |
Normal_Weight-vs-Extreme_Weight |
8.894400E-01 |
Normal_Weight-vs-Obese |
2.920800E-01 |
Normal_Weight-vs-Extreme_Obese |
9.772800E-01 |
Extreme_Weight-vs-Obese |
3.047400E-01 |
Extreme_Weight-vs-Extreme_Obese |
9.581600E-01 |
Obese-vs-Extreme_Obese |
5.431800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.256500E-03 |
Normal-vs-Age(41-60Yrs) |
3.59620000000005E-05 |
Normal-vs-Age(61-80Yrs) |
9.80909797831941E-11 |
Normal-vs-Age(81-100Yrs) |
1.47959999996505E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.174000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.202600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.311800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.204900E-03 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.734200E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.259200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.62460999999503E-05 |
Normal-VS-Type2 PRCC |
6.08402217494586E-14 |
Normal-VS-KIRP CIMP |
2.2772999999976E-05 |
Normal-VS-Unclassified PRCC |
2.382900E-04 |
Type1 PRCC-VS-Type2 PRCC |
4.19399999951331E-07 |
Type1 PRCC-VS-KIRP CIMP |
1.281830E-01 |
Type1 PRCC-VS-Unclassified PRCC |
3.154200E-01 |
Type2 PRCC-VS-KIRP CIMP |
6.014400E-01 |
Type2 PRCC-VS-Unclassified PRCC |
1.599520E-02 |
KIRP CIMP-VS-Unclassified PRCC |
3.880000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.42740050282464E-10 |
Normal-vs-N1 |
3.996900E-04 |
Normal-vs-N2 |
3.6075999999996E-05 |
N0-vs-N1 |
3.603600E-01 |
N0-vs-N2 |
3.650600E-01 |
N1-vs-N2 |
3.111600E-01 |
|
|